A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood.
D000293:Adolescent; D000505:Alopecia / Q000139:chemically induced; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D003556:Cystitis / Q000139:chemically induced; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000209:etiology; D007019:Hypoproteinemia / Q000209:etiology; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D009404:Nephrotic Syndrome / Q000150:complications / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use*; D011446:Prospective Studies; D011507:Proteinuria / Q000188:drug therapy / Q000209:etiology; D012008:Recurrence
D003520:Cyclophosphamide; D011241:Prednisone